A novel biosensor for the monitoring of ovarian cancer tumor protein CA 125 in untreated human plasma samples using a novel nano-ink: a new platform for efficient diagnosis of cancer using paper based microfluidic technology

Arezoo Saadati, Soodabeh Hassanpour, Farnaz Bahavarnia, Mohammad Hasanzadeh

Analytical Methods · 2020 · 47 citations · 42 references

Concepts

Abstract

Carcinoma antigen 125 (CA 125) has been recognized as a clinical glycoprotein/biomarker for the early-stage detection of ovarian cancer.

References

42